identifi
nurs
asymptomat
sarscov
infect
work
sar
ward
sinc
diseas
outbreak
use
full
infect
control
procedur
recommend
world
health
organ
nurs
perform
procedur
includ
nasopharyng
aspir
handl
fecal
matter
oral
feed
sar
patient
sar
develop
six
colleagu
work
ward
unprotect
exposur
colleagu
contract
sar
requir
hospit
serolog
test
sarscov
antibodi
perform
microbiolog
laboratori
princess
margaret
hospit
week
nurs
sar
ward
duti
result
test
posit
enzymelink
immunosorb
assay
test
repeat
govern
viru
unit
depart
health
one
refer
laboratori
hong
kong
second
test
also
show
posit
result
antibodi
titer
immunofluoresc
assay
normal
perform
anoth
serolog
test
week
sar
ward
duti
result
posit
nurs
interview
two
physician
question
health
condit
sinc
februari
report
symptom
typic
sar
fever
chill
rigor
malais
myalgia
cough
dyspnea
diarrhea
sar
ward
duti
mild
shortterm
headach
period
mani
year
take
sick
leav
sinc
februari
record
rise
bodi
temperatur
leukocyt
count
x
l
lymphocyt
count
x
l
result
liver
renal
function
test
normal
revers
transcriptionpolymeras
chain
reaction
result
sarscov
stool
urin
throat
nasal
swab
collect
week
sar
ward
duti
neg
abnorm
radiolog
chang
identifi
lung
live
four
famili
member
close
contact
none
famili
member
contract
sar
show
neg
result
serolog
test
sarscov
think
asymptomat
subclin
infect
sarscov
exist
result
seroconvers
howev
kind
asymptomat
seroconvers
probabl
uncommon
person
infect
sarscov
typic
symptom
infect
asymptomat
person
unknown
person
genet
makeup
may
determin
suscept
sarscov
final
clinic
outcom
agre
seto
et
al
recal
bia
concern
howev
recal
bia
probabl
littl
effect
sinc
event
took
place
recent
moreov
hospit
nurs
infect
colleagu
would
made
alert
awar
symptom
ill
editor
preval
chronic
hepat
c
viru
hcv
among
blood
donor
assess
west
african
countri
recent
estim
rang
recent
metaanalysi
studi
includ
confirm
test
yield
averag
preval
hcv
infect
systemat
screen
hcv
infect
occur
among
blood
donor
seneg
blood
donat
legisl
still
pend
report
assess
proport
blood
donor
princip
de
dakar
hcv
antibodi
blood
donor
volunt
recruit
independ
hospit
patient
regist
local
donor
associ
screen
risk
factor
bloodborn
infect
potenti
donor
clinic
examin
confidenti
questionnair
person
histori
jaundic
risk
behavior
exclud
serum
sampl
collect
blood
donor
june
decemb
screen
hcv
antibodi
thirdgener
enzym
immunoassay
eia
hcv
murex
abbott
laboratori
abbott
il
year
men
firsttim
donor
account
younger
repeat
donor
mean
year
vs
year
p
eia
hcv
antibodi
found
donor
immunoblot
assay
posit
nine
yield
overal
preval
exact
confid
interv
eight
nine
repeat
donor
differ
preval
compar
firsttim
donor
reach
statist
signific
vs
hcvinfect
donor
tend
older
uninfect
donor
mean
year
vs
year
median
year
vs
year
mannwhitney
test
p
trend
age
signific
year
year
year
year
chisquar
trend
p
alat
level
infect
studi
particip
normal
rang
iu
one
particip
alat
level
normal
genotyp
identifi
line
immunoassayposit
sampl
three
sampl
test
hbsag
detect
new
donor
coinfect
hcv
hepat
b
viru
found
preval
hcv
antibodi
blood
donor
dakar
appear
one
lowest
west
africa
close
publish
estim
mauritania
benin
respect
lower
west
african
countri
ghana
guinea
preval
rang
find
keep
result
hospit
casecontrol
studi
hcv
infect
liver
cirrhosi
cancer
conduct
dakar
studi
identifi
hcv
infect
control
casepati
hcv
antibodi
convers
high
hcv
preval
found
group
risk
antibodi
present
hemodialysi
patient
hcv
rna
found
hvc
antibodyposit
patient
genotyp
studi
cohort
patient
receiv
highli
activ
antiretrovir
therapi
posit
hcv
serolog
result
urban
set
dakar
hcv
infect
seem
still
confin
group
risk
contribut
hcv
chronic
liver
diseas
yet
demonstr
approxim
blood
donat
annual
made
dakar
systemat
screen
hcv
antibodi
blood
donor
could
prevent
averag
bloodborn
hcv
infect
year
given
data
price
eia
lia
screen
cost
per
hcvposit
sampl
identifi
infect
subsequ
avert
approxim
cfa
us
estim
low
sinc
includ
margin
cost
reagent
kit
screen
cost
could
reduc
discard
blood
unit
test
posit
one
enzymelink
immunosorb
assay
cfa
us
price
nearli
blood
unit
wrongli
discard
franc
demonstr
strategi
best
costeffect
ratio
long
preval
remain
cost
compar
favor
cost
per
hiv
infect
avert
improv
blood
safeti
rang
us
assess
highli
hivpreval
southern
african
countri
tanzania
zambia
zimbabw
hcvposit
discard
blood
unit
ad
